海王星科技
NEPT

股本结构

单位：万股
公告日期 2024-02-16 2023-11-14 2023-09-25 2023-09-25 2023-09-07 2023-08-17
证券总股本 453.20 200.91 85.31 60.31 60.00 2411.76
普通股本 453.20 200.91 85.31 60.31 60.00 2411.76
优先股 未披露 未披露 未披露 未披露 未披露 未披露
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2023-11-13 2023-09-30 2023-09-26 2023-09-21 2023-09-08 2023-08-16
注释：中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本（万股） 变动后优先股（万股） 变动原因 变动日期
2024-02-16 453.20 未披露
更多>>
From September 30, 2023 to November 13, 2023 Common shares issued in relation with the settlement of a litigation
2023-11-13
2023-11-14 200.91 未披露
更多>>
From March 31, 2023 to September 30, 2023 Total contributions by and distribution to equity holders Warrants exercised Direct Offering (including pre-funded warrants), net of issuance costs
2023-09-30
2023-09-25 85.31 未披露
更多>>
Common Shares offered 250,000 Common Shares by the company
2023-09-26
2023-09-25 60.31 未披露 定期报告 2023-09-21
2023-09-07 60.00 未披露
更多>>
Neptune Wellness Solutions Inc. announced further to its news release on August 22, 2023, the completion of the Company's proposed consolidation of its common shares (the "Common Shares") on the basis of one (1) post-consolidation Common Share for every forty (40) pre-consolidation Common Shares (the "Consolidation").
2023-09-08
2023-08-17 2411.76 未披露 定期报告 2023-08-16
2023-08-17 2182.21 未披露
更多>>
From March 31, 2023 to June 30, 2023 Warrants exercised Direct Offering (including pre-funded warrants), net of issuance costs Total contributions by and distribution to equity holders
2023-06-30
2023-05-12 1641.15 未披露
更多>>
Common Shares offered 4,415,162 Common Shares by the company
2023-05-15
2023-07-17 1199.64 未披露
更多>>
From March 31, 2022 to March 31, 2023 Common shares and warrants issued in connection with debt financing Common shares issued in exchange of services rendered by non-employees Warrants exercised RSUs released, net of withholding taxes Direct Offering (including pre-funded warrants), net of issuance costs
2023-03-31
2023-03-30 1199.63 未披露 定期报告 2023-03-29
2023-01-30 1185.01 未披露 定期报告 2023-01-24
2023-03-30 1177.84 未披露
更多>>
From March 31, 2022 to December 31, 2022 Common shares issued in connection with debt financing Warrants exercised RSUs released, net of withholding taxes Direct Offering, net of issuance costs
2022-12-31
2022-10-12 1172.55 未披露
更多>>
1.Today announced that it has closed the previously announced offering of 3,208,557 common shares of the Company
2022-10-12
2022-10-11 851.69 未披露 定期报告 2022-10-07
2022-12-20 851.69 未披露
更多>>
From March 31, 2022 to September 30, 2022 Common shares issued in connection with debt financing Warrants exercised RSUs released, net of withholding taxes Direct Offering, net of issuance costs
2022-09-30
2022-08-25 836.51 未披露 定期报告 2022-08-25
2022-09-27 798.98 未披露 定期报告 2022-08-04
2022-07-19 798.71 未披露
更多>>
In connection with the Amended Note, on July 13, 2022, the Registrant issued 372,670 common shares (the "Common Shares") to MSEC at a price per share equal to $1.61 for total cash consideration of $600,000.
2022-07-13
2022-08-15 761.44 未披露
更多>>
From March 31, 2022 to June 30, 2022 Direct Offering, net of issuance costs Total contributions by and distribution to equity holders RSUs released, net of withholding taxes
2022-06-30
2022-06-22 566.89 未披露 定期报告 2022-06-21
2022-06-08 570.00 未披露
更多>>
Neptune Wellness Solutions Inc. announced today that it has received conditional approval of the Toronto Stock Exchange ("TSX") with respect to the Company's proposed consolidation of its common shares (the "Common Shares") on the basis of one (1) post-consolidation Common Share for every thirty-five (35) pre-consolidation Common Shares (the "Consolidation"). The Consolidation will reduce the number of Common Shares issued and outstanding from approximately 198 million Common Shares to approximately 5.7 million Common Shares.
2022-06-13
2022-06-08 19800.00 未披露 定期报告 2022-06-08
2022-03-14 18785.85 未披露
更多>>
1.Securities offered 18,500,000 Offered Shares 2.The number of common shares to be outstanding immediately after this offering as shown above is based on 169,358,521 common shares outstanding as of March 9, 2022.
2022-03-14
2022-03-14 16926.42 未披露 定期报告 2022-03-10
2022-03-10 16935.85 未披露 定期报告 2022-03-09
2022-02-10 16745.84 未披露 定期报告 2022-02-10
2022-01-28 16741.12 未披露 定期报告 2022-01-28
2021-11-15 16731.69 未披露 定期报告 2021-11-15
2022-01-28 16726.97 未披露 定期报告 2021-09-30
2021-08-12 16717.54 未披露 定期报告 2021-08-11
2021-08-12 16708.10 未披露
更多>>
From March 31, 2021 to June 29, 2021 RSUs released, net of tax
2021-06-29
2021-07-16 16562.29 未披露
更多>>
From March 31, 2020 To March 31, 2021 Share options exercised DSUs released RSUs released, net of tax Restricted shares issued At-The-Market Offering, net of issuance costs Direct Offering, net of issuance costs Private Placement, net of issuance costs Business combinations Registered Direct Offering Priced At-The-Market and Concurrent Private Placement, net of issuance costs
2021-03-31
2021-03-26 16557.51 未披露 定期报告 2021-03-25
2021-02-19 15699.67 未披露
更多>>
1.Neptune Wellness Solutions Inc. today announced it has closed on the previously announced registered direct offering with institutional investors for the purchase of 27,500,000 common shares and the private placement of unregistered common share purchase warrants (the "Warrants") to purchase 6,875,000 common shares.
2021-02-19
2021-02-19 13799.25 未披露 定期报告 2021-02-17
2021-02-16 13799.25 未披露 定期报告 2021-02-16
2021-02-16 12959.24 未披露
更多>>
From March 31, 2020 to December 31, 2020 Share options exercised DSUs released RSUs released, net of tax Restricted shares issued At-The-Market Offering, net of issuance costs Direct Offering, net of issuance costs Private Placement, net of issuance costs
2020-12-31
2020-11-20 12949.67 未披露 定期报告 2020-11-19
2020-11-16 12949.67 未披露 定期报告 2020-11-15
2020-10-23 11257.09 未披露 定期报告 2020-10-23
2020-11-16 11255.95 未披露
更多>>
From March 31, 2020 to September 30, 2020 Share options exercised DSUs released RSUs released, net of tax Restricted shares issued At-The-Market Offering, net of issuance costs Direct Offering, net of issuance costs
2020-09-30
2020-07-15 10660.16 未披露 定期报告 2020-07-13
2020-07-16 10659.26 未披露 定期报告 2020-07-08
2020-08-11 10658.60 未披露
更多>>
From March 31, 2020 to June 30, 2020 Share options exercised DSUs released RSUs released, net of tax Restricted shares issued At-The-Market Offering, net of issuance costs
2020-06-30
2020-06-10 10621.77 未披露 定期报告 2020-06-10
2020-06-10 9933.81 未披露
更多>>
From March 31, 2019 to March 31, 2020 Warrants exercised Share options exercised DSUs released RSUs released, net of tax Private placement, net of issuance costs At-The-Market Offering, net of issuance costs Business acquisition Provisions settled in shares
2020-03-31
2020-02-13 9495.48 未披露 定期报告 2020-02-12
2019-08-14 9247.13 未披露 定期报告 2019-08-13
2019-08-14 8146.81 未披露
更多>>
from March 31, 2019 to June 30, 2019 Warrants exercised Share options exercised Provisions settled in shares
2019-06-30
2019-07-18 8138.02 未披露 定期报告 2019-06-26
2019-06-12 8134.89 未披露 定期报告 2019-06-12
2019-06-12 7998.73 未披露
更多>>
from December 31, 2018 to February 22, 2019 DSU released Share options exercised
2019-02-22
2019-02-13 7997.68 未披露 定期报告 2019-02-13
2019-02-13 7995.77 未披露
更多>>
from March 31, 2018 to December 31, 2018 DSU released Share options exercised
2018-12-31
2018-11-13 7990.43 未披露 定期报告 2018-11-13
2018-11-13 7980.94 未披露
更多>>
from March 31, 2018 to September 30, 2018 DSU released Share options exercised
2018-09-30
2018-08-14 7926.27 未披露 定期报告 2018-08-14
2018-08-14 7923.77 未披露
更多>>
from March 31, 2018 to June 30, 2018 Contributions by and distribution to equity holders Share-based payment transactions Share options exercised
2018-06-30
2018-07-18 7922.17 未披露 定期报告 2018-06-25
2018-06-05 7885.07 未披露 定期报告 2018-06-05
2018-02-14 7880.42 未披露 定期报告 2018-02-14
2017-11-14 7865.52 未披露
更多>>
from March 31, 2017 to September 30, 2017 DSU released Liability settled in shares Total contributions by and distribution to equity holders Total transactions with equity holders
2017-09-30
2017-08-14 7864.03 未披露 定期报告 2017-08-14
2017-08-14 7860.53 未披露
更多>>
from March 31, 2017 to June 30, 2017 Liability settled in shares
2017-06-30
2017-07-17 7857.62 未披露 定期报告 2017-06-28
2016-07-11 7794.55 未披露 定期报告 2016-07-11
2016-07-11 7794.55 未披露 定期报告 2016-05-31
2016-05-26 7794.55 未披露
更多>>
from February 28, 2015 to February 29, 2016 Transactions with owners, recorded directly in equity Contributions by and distribution to owners Exercise of warrants RSUs released Business acquisition
2016-02-29
2016-01-12 7794.18 未披露 定期报告 2016-01-12
2015-10-14 7536.68 未披露
更多>>
From February 28, 2015 to July 13, 2015 Transactions with owners, recorded directly in equity Contributions by and distribution to owners Exercise of Neptune series 2011-1 warrants RSUs released
2015-07-13
2015-06-18 7538.03 未披露 定期报告 2015-06-09
2015-07-13 7535.12 未披露
更多>>
From February 28, 2015 to May 31, 2015 Transactions with owners, recorded directly in equity Contributions by and distribution to owners Exercise of Neptune series 2011-1 warrants
2015-05-31
2015-05-28 7535.11 未披露
更多>>
from February 28, 2014 to February 28, 2015 Share-based payment transactions with a consultant Share options exercised RSUs released Public offering Private placement Plan of arrangement of NeuroBioPharm
2015-02-28
2014-07-15 7497.97 未披露 定期报告 2014-07-15
2014-07-15 7438.64 未披露
更多>>
from February 28, 2014 to May 21, 2014 Transactions with owners, recorded directly in equity：Share-based payment transactions with a consultant Transactions with owners, recorded directly in equity：Public offering Transactions with owners, recorded directly in equity：Private placement
2014-05-21
2014-05-28 7441.55 未披露 定期报告 2014-04-30
2014-05-22 6187.87 未披露
更多>>
from February 28, 2013 to February 28, 2014 Contributions by and distribution to owners: Share-based payment transactions with a consultant Share options exercised RSUs released
2014-02-28
2014-01-14 6128.46 未披露
更多>>
from February 28, 2013 to November 30, 2013 Share-based payment transactions with a consultant Share options and RSUs exercised Total contributions by and distribution to owners Total transactions with owners
2013-11-30
2013-10-15 6100.29 未披露
更多>>
from February 28, 2013 to August 31, 2013 Share-based payment transactions with a consultant Share options and RSUs exercised
2013-08-31
2013-07-15 6011.97 未披露
更多>>
From February 28, 2013 to May 31, 2013 Transactions with owners, recorded directly in equity - Contributions by and distribution to owners: Share options exercised
2013-05-31
2013-05-30 6007.97 未披露
更多>>
From February 29, 2012 to February 28, 2013 Transactions with owners, recorded directly in equity - Contributions by and distribution to owners:Public offering Transactions with owners, recorded directly in equity - Contributions by and distribution to owners:Warrants exercised Transactions with owners, recorded directly in equity - Contributions by and distribution to owners:Share options exercised
2013-02-28
2013-01-14 6006.47 未披露
更多>>
from February 29, 2012 to November 30, 2012 Public offering Warrants exercised Share options exercised
2012-11-30
2012-09-20 5017.11 未披露 定期报告 2012-09-18
2012-09-14 5016.11 未披露 定期报告 2012-09-10
2012-07-16 4980.71 未披露
更多>>
from February 29, 2012 to May 31, 2012 Warrants exercised Share options exercised
2012-05-31
2012-01-17 4968.88 未披露
更多>>
from February 28, 2011 to November 30, 2011 Issuance of shares and warrants through private placement Share options exercised Warrants exercised
2011-11-30
2011-10-14 4941.78 未披露
更多>>
from February 28, 2011 to August 31, 2011 Issuance of shares and warrants through private placement Share options exercised Warrants exercised
2011-08-31
2011-05-31 4249.09 未披露
更多>>
from February 28, 2010 to February 28, 2011 Exercise of stock options: Cash Exercise of warrants:Cash Conversion of convertible debentures Private placement
2011-02-28
2010-08-31 3823.47 未披露
更多>>
from Feb 28,2009 to Feb 28,2010 Conversion of convertible debentures Exercise of stock options Cash Exercise of warrants
2010-02-28
2009-08-31 3768.34 未披露
更多>>
from May 31, 2008 to February 28, 2009 Issued the exercise of stock options
2009-02-28
2009-08-31 3748.18 未披露
更多>>
from May 31, 2007 to May 31, 2008 Issued the exercise of stock options
2008-05-31
From September 30, 2023 to November 13, 2023 Common shares issued in relation with the settlement of a litigation
From March 31, 2023 to September 30, 2023 Total contributions by and distribution to equity holders Warrants exercised Direct Offering (including pre-funded warrants), net of issuance costs
Common Shares offered 250,000 Common Shares by the company
Neptune Wellness Solutions Inc. announced further to its news release on August 22, 2023, the completion of the Company's proposed consolidation of its common shares (the "Common Shares") on the basis of one (1) post-consolidation Common Share for every forty (40) pre-consolidation Common Shares (the "Consolidation").
From March 31, 2023 to June 30, 2023 Warrants exercised Direct Offering (including pre-funded warrants), net of issuance costs Total contributions by and distribution to equity holders
Common Shares offered 4,415,162 Common Shares by the company
From March 31, 2022 to March 31, 2023 Common shares and warrants issued in connection with debt financing Common shares issued in exchange of services rendered by non-employees Warrants exercised RSUs released, net of withholding taxes Direct Offering (including pre-funded warrants), net of issuance costs
From March 31, 2022 to December 31, 2022 Common shares issued in connection with debt financing Warrants exercised RSUs released, net of withholding taxes Direct Offering, net of issuance costs
1.Today announced that it has closed the previously announced offering of 3,208,557 common shares of the Company
From March 31, 2022 to September 30, 2022 Common shares issued in connection with debt financing Warrants exercised RSUs released, net of withholding taxes Direct Offering, net of issuance costs
In connection with the Amended Note, on July 13, 2022, the Registrant issued 372,670 common shares (the "Common Shares") to MSEC at a price per share equal to $1.61 for total cash consideration of $600,000.
From March 31, 2022 to June 30, 2022 Direct Offering, net of issuance costs Total contributions by and distribution to equity holders RSUs released, net of withholding taxes
Neptune Wellness Solutions Inc. announced today that it has received conditional approval of the Toronto Stock Exchange ("TSX") with respect to the Company's proposed consolidation of its common shares (the "Common Shares") on the basis of one (1) post-consolidation Common Share for every thirty-five (35) pre-consolidation Common Shares (the "Consolidation"). The Consolidation will reduce the number of Common Shares issued and outstanding from approximately 198 million Common Shares to approximately 5.7 million Common Shares.
1.Securities offered 18,500,000 Offered Shares 2.The number of common shares to be outstanding immediately after this offering as shown above is based on 169,358,521 common shares outstanding as of March 9, 2022.
From March 31, 2021 to June 29, 2021 RSUs released, net of tax
From March 31, 2020 To March 31, 2021 Share options exercised DSUs released RSUs released, net of tax Restricted shares issued At-The-Market Offering, net of issuance costs Direct Offering, net of issuance costs Private Placement, net of issuance costs Business combinations Registered Direct Offering Priced At-The-Market and Concurrent Private Placement, net of issuance costs
1.Neptune Wellness Solutions Inc. today announced it has closed on the previously announced registered direct offering with institutional investors for the purchase of 27,500,000 common shares and the private placement of unregistered common share purchase warrants (the "Warrants") to purchase 6,875,000 common shares.
From March 31, 2020 to December 31, 2020 Share options exercised DSUs released RSUs released, net of tax Restricted shares issued At-The-Market Offering, net of issuance costs Direct Offering, net of issuance costs Private Placement, net of issuance costs
From March 31, 2020 to September 30, 2020 Share options exercised DSUs released RSUs released, net of tax Restricted shares issued At-The-Market Offering, net of issuance costs Direct Offering, net of issuance costs
From March 31, 2020 to June 30, 2020 Share options exercised DSUs released RSUs released, net of tax Restricted shares issued At-The-Market Offering, net of issuance costs
From March 31, 2019 to March 31, 2020 Warrants exercised Share options exercised DSUs released RSUs released, net of tax Private placement, net of issuance costs At-The-Market Offering, net of issuance costs Business acquisition Provisions settled in shares
from March 31, 2019 to June 30, 2019 Warrants exercised Share options exercised Provisions settled in shares
from December 31, 2018 to February 22, 2019 DSU released Share options exercised
from March 31, 2018 to December 31, 2018 DSU released Share options exercised
from March 31, 2018 to September 30, 2018 DSU released Share options exercised
from March 31, 2018 to June 30, 2018 Contributions by and distribution to equity holders Share-based payment transactions Share options exercised
from March 31, 2017 to September 30, 2017 DSU released Liability settled in shares Total contributions by and distribution to equity holders Total transactions with equity holders
from March 31, 2017 to June 30, 2017 Liability settled in shares
from February 28, 2015 to February 29, 2016 Transactions with owners, recorded directly in equity Contributions by and distribution to owners Exercise of warrants RSUs released Business acquisition
From February 28, 2015 to July 13, 2015 Transactions with owners, recorded directly in equity Contributions by and distribution to owners Exercise of Neptune series 2011-1 warrants RSUs released
From February 28, 2015 to May 31, 2015 Transactions with owners, recorded directly in equity Contributions by and distribution to owners Exercise of Neptune series 2011-1 warrants
from February 28, 2014 to February 28, 2015 Share-based payment transactions with a consultant Share options exercised RSUs released Public offering Private placement Plan of arrangement of NeuroBioPharm
from February 28, 2014 to May 21, 2014 Transactions with owners, recorded directly in equity：Share-based payment transactions with a consultant Transactions with owners, recorded directly in equity：Public offering Transactions with owners, recorded directly in equity：Private placement
from February 28, 2013 to February 28, 2014 Contributions by and distribution to owners: Share-based payment transactions with a consultant Share options exercised RSUs released
from February 28, 2013 to November 30, 2013 Share-based payment transactions with a consultant Share options and RSUs exercised Total contributions by and distribution to owners Total transactions with owners
from February 28, 2013 to August 31, 2013 Share-based payment transactions with a consultant Share options and RSUs exercised
From February 28, 2013 to May 31, 2013 Transactions with owners, recorded directly in equity - Contributions by and distribution to owners: Share options exercised
From February 29, 2012 to February 28, 2013 Transactions with owners, recorded directly in equity - Contributions by and distribution to owners:Public offering Transactions with owners, recorded directly in equity - Contributions by and distribution to owners:Warrants exercised Transactions with owners, recorded directly in equity - Contributions by and distribution to owners:Share options exercised
from February 29, 2012 to November 30, 2012 Public offering Warrants exercised Share options exercised
from February 29, 2012 to May 31, 2012 Warrants exercised Share options exercised
from February 28, 2011 to November 30, 2011 Issuance of shares and warrants through private placement Share options exercised Warrants exercised
from February 28, 2011 to August 31, 2011 Issuance of shares and warrants through private placement Share options exercised Warrants exercised
from February 28, 2010 to February 28, 2011 Exercise of stock options: Cash Exercise of warrants:Cash Conversion of convertible debentures Private placement
from Feb 28,2009 to Feb 28,2010 Conversion of convertible debentures Exercise of stock options Cash Exercise of warrants
from May 31, 2008 to February 28, 2009 Issued the exercise of stock options
from May 31, 2007 to May 31, 2008 Issued the exercise of stock options
同花顺个股页面 | 模拟炒股 | 股民学校 | 手机炒股| 联系我们

免责声明:本信息由同花顺金融研究中心提供，仅供参考，同花顺金融研究中心力求但不保证数据的完全准确，如有错漏请以中国证监会指定上市公司信息披露媒体为准，同花顺金融研究中心不对因该资料全部或部分内容而引致的盈亏承担任何责任。用户个人对服务的使用承担风险。同花顺对此不作任何类型的担保。同花顺不担保服务一定能满足用户的要求，也不担保服务不会受中断，对服务的及时性，安全性，出错发生都不作担保。同花顺对在同花顺上得到的任何信息服务或交易进程不作担保。同花顺提供的包括同花顺理财的所有文章，数据，不构成任何的投资建议，用户查看或依据这些内容所进行的任何行为造成的风险和结果都自行负责，与同花顺无关。

【免责声明】本产品中的行情数据及资讯信息来源于第三方，长江证券不对收集数据的版权、真实性、准确性及传输过程中发生的传送错误承担法律责任。本内容仅供参考，不作为投资决策依据，长江证券不对因据此操作产生的盈亏承担任何责任。投资有风险，入市需谨慎。